Jan 28, 2022

FRIDAY, Jan. 28, 2022 (HealthDay News) -- For patients with rheumatoid arthritis aged 50 years or older with one or more additional cardiovascular risk factors, increased risks for major adverse cardi...

Jan 28, 2022

THURSDAY, Jan. 27, 2022 (HealthDay News) -- The youngest adults have the greatest burden of distant-stage early-onset colorectal adenocarcinoma, according to a study published online Jan. 26 in Cancer...

Jan 27, 2022

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Low-dose computed tomography (LDCT) screening of mostly nonsmoking Asian women is associated with considerable early-stage lung cancer overdiagnosis, accor...

Jan 27, 2022

TUESDAY, Jan. 25, 2022 (HealthDay News) -- A composite score can identify patients with chronic lymphocytic leukemia (CLL) with very low risk for requiring treatment, according to a study published on...

Jan 27, 2022

TUESDAY, Jan. 25, 2022 (HealthDay News) -- A four-marker protein panel (4MP), including the precursor form of surfactant protein B, cancer antigen 125, carcinoembryonic antigen, and cytokeratin-19 fra...

Jan 27, 2022

TUESDAY, Jan. 25, 2022 (HealthDay News) -- A four-marker protein panel (4MP), including the precursor form of surfactant protein B, cancer antigen 125, carcinoembryonic antigen, and cytokeratin-19 fra...

Jan 27, 2022

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Low-dose computed tomography (LDCT) screening of mostly nonsmoking Asian women is associated with considerable early-stage lung cancer overdiagnosis, accor...

Jan 25, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- Black patients are more likely than White patients to have at least one negative descriptor in the history and physical notes of their electronic health recor...

Jan 25, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- Night shift work may increase the risk for chronic lymphocytic leukemia (CLL), according to a study published online Jan. 13 in Occupational & Environmental M...

Jan 24, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- Adding the immunotherapeutic agent durvalumab to standard chemotherapy improves survival in advanced biliary tract cancer, according to a study presented at t...

Jan 24, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- STRIDE (Single tremelimumab Regular Interval durvalumab) is proposed as first-line therapy for unresectable hepatocellular carcinoma (uHCC), according to a st...

Jan 24, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism (VTE), according to a research letter published o...

Jan 24, 2022

MONDAY, Jan. 24, 2022 (HealthDay News) -- For patients with lymphoid malignancies undergoing autologous hematopoietic stem cell transplantation (aHSCT), frailty is associated with worse hospital outco...

Jan 24, 2022

Researchers have developed a prognostic test to direct adjuvant chemotherapy (ACT) decision in early-stage non-small cell lung cancer (NSCLC) adenocarcinomas. The purpose of their study was to weigh u...

Jan 24, 2022

. Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare aggressive renal malignancy associated with hereditary leiomyomatosis and RCC syndrome (HLRCC). Tumors exhibiting heterogeneous...

Jan 24, 2022

Randomised trials have investigated various androgen deprivation therapy (ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate cancer. This individual patient da...

Jan 24, 2022

During disease progression from primary towards metastatic prostate cancer (PCa), and in particular bone metastases, the tumor microenvironment (TME) evolves in parallel with the cancer clones, alteri...

Jan 24, 2022

Proteins secreted by cells play significant roles in mediating many physiological, developmental, and pathological processes due to their functions in intra/intercellular communication and signaling. ...

Jan 24, 2022

Chimeric antigen receptor (CAR) T-cell immunotherapies targeting CD19 can achieve impressive clinical remission rates in the treatment of B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leu...

Jan 24, 2022

Histone lysine specific demethylase 1 (LSD1) is a promising new therapeutic target for cancer therapy. Following the work on the discovery of natural LSD1 inhibitor higenamine, we herein performed fur...